Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Troponin I type 1 (skeletal, slow) is a muscle-specific regulatory protein encoded by the TNNI1 gene and predominately expressed in slow-twitch skeletal muscle fibers. It is one of three subunits of the troponin complex, where it serves as the inhibitory component that prevents actin-myosin interactions, thus regulating contraction and relaxation through its calcium-dependent conformational change[1][2]. TNNI1 is essential for normal muscle function, fine-tuning the calcium sensitivity of force development. Pathogenic variants cause a spectrum of myopathies, with loss-of-function mutations leading to muscle weakness, and gain-of-function mutations associated with hypercontractile symptoms[3]. TNNI1 can serve as a specific biomarker for slow-twitch muscle injury and has attracted experimental therapeutic research, but it is not classified as a conventional drug target like a receptor or enzyme[1][2][3].
Activators: Increase contractility by sensitizing the troponin complex to calcium (for loss-of-function TNNI1 variants); Inhibitors: Reduce excessive contractility by inhibiting myosin activity (for gain-of-function TNNI1 variants)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Troponin I type 1 (skeletal, slow) (TNNI1).